Insider Transactions in Q1 2021 at Harpoon Therapeutics, Inc. (HARP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2021
|
Georgia Erbez Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.7%
|
$50,000
$2.12 P/Share
|
|
Feb 10
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
183,051
-5.35%
|
$3,661,020
$20.0 P/Share
|
|
Feb 09
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
9,400
-0.27%
|
$188,000
$20.25 P/Share
|
|
Feb 08
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
72,128
-2.06%
|
$1,442,560
$20.04 P/Share
|
|
Feb 05
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
10,172
-0.29%
|
$203,440
$20.01 P/Share
|
|
Feb 04
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
29,730
-0.84%
|
$594,600
$20.37 P/Share
|
|
Feb 03
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
41,922
-1.17%
|
$838,440
$20.21 P/Share
|
|
Feb 02
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
48,421
-1.33%
|
$968,420
$20.13 P/Share
|
|
Jan 27
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
706,825
-16.29%
|
$14,136,500
$20.0 P/Share
|
|
Jan 26
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,363
-0.03%
|
$28,623
$21.08 P/Share
|
|
Jan 25
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
13,006
-0.3%
|
$273,126
$21.23 P/Share
|
|
Jan 22
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
24,695
-0.56%
|
$518,595
$21.72 P/Share
|
|
Jan 21
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
26,066
-0.2%
|
$573,452
$22.83 P/Share
|
|
Jan 20
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
101,646
-2.26%
|
-
|
|
Jan 20
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
17,694
-0.2%
|
$424,656
$24.33 P/Share
|
|
Jan 11
2021
|
Ronald Hunt |
BUY
Open market or private purchase
|
Indirect |
235,294
+20.48%
|
$3,999,998
$17.0 P/Share
|
|
Jan 11
2021
|
New Leaf Ventures Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
235,294
+20.48%
|
$3,999,998
$17.0 P/Share
|
|
Jan 04
2021
|
Holger Wesche Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.61%
|
$180,000
$18.34 P/Share
|
|
Jan 04
2021
|
Holger Wesche Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+13.73%
|
$0
$0.6 P/Share
|